Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to improve blood sugar control and support significant weight loss. By mimicking natural gut hormones, it enhances insulin sensitivity, suppresses appetite, and promotes fat metabolism, making it a groundbreaking treatment for type 2 diabetes and obesity.